“hiv” Archives

in
Entry Author Date Location
Biotech and Fantasy Football Picks for Fall 2013 09/03/13 National
Sangamo in Race to Replace Chronic Drug Treatment with Gene Therapies 07/15/13 San Francisco
Gilead Sciences Building on HIV, Becoming Cancer Drug Force 04/01/13 National
Drug Development: Let’s Play! 03/21/13 Seattle
If You’ve Got a Real Breakthrough, the FDA Wants To Talk 01/14/13 National
Bridesmaid No More: It is Time For Diagnostics To Shine 07/02/12 National
AIDS Drugs Were the Start. Let’s See More FDA Accelerated Approvals 03/12/12 National
Biotech Is Raising More Cash, But Don’t Be Fooled: Startups are Hurting 01/23/12 National
Merck Leads $10M Funding of HIV Diagnostics Firm Daktari 01/03/12 Boston
The Hepatitis C Market: Biotech’s Version of the Daytona 500 12/12/11 National
Theraclone Names Cliff Stocks, Vet of Icos & Calistoga, as New CEO 12/06/11 Seattle
Sangamo Fails Diabetic Neuropathy Study, Falls Back on HIV, Other Programs 10/03/11 San Francisco
Gates Foundation Adds Novartis Vet, Trevor Mundel, as New Global Health Leader 09/13/11 Seattle
Theraclone Snaps Up $10.6M Financing 09/08/11 Seattle
(Mis)Understanding Drug Discovery: It’s Much Harder Than Rocket Science 09/07/11 Seattle
Theraclone Nabs Industry Award, Scopes Out Extra $10M Financing 09/06/11 Seattle
Dramatic Changes in Hepatitis C Treatment Expected to Continue 09/06/11 San Diego
Seattle Genetics’ Market Debut, Pathway Gets Bought, Theraclone’s Latest Trick Against HIV, & More Seattle-Area Life Sciences News 08/25/11 Seattle
Consortium Find New HIV Antibodies, Zogenix Gets Drug to Clinical End Point, TrovaGene Reclaims Technology, & More San Diego Life Sciences News 08/18/11 San Diego
Scientists Spot New Antibodies Against HIV, Opening Up Potential Path to AIDS Vaccine 08/17/11 National
Gilead HIV Drug Gets FDA OK 08/10/11 San Francisco
Merck and UCSF Team Up to Find New Weapons Against Resurgent HIV 07/20/11 New York
Ken Stuart, the Working Class Kid Who Built a Global Health Hotspot at Seattle Biomed 07/20/11 Seattle
SeaGen’s Big Day at the FDA, Hutch Nabs $20M HIV Grant, Allozyne’s Nasdaq Plan, & More Seattle-Area Life Sciences News 07/14/11 Seattle
Gilead Expands Low-Cost HIV Drug Program 07/12/11 San Francisco
Hutch, Sangamo Win $20M HIV Grant 07/11/11 Seattle
Tachi Yamada, Former Gates Foundation Leader, Joins Frazier for New VC Gig 06/27/11 Seattle
Concert Pharmaceuticals Hits $4 Million Milestone in GSK Alliance 06/20/11 Boston
AVI Biopharma CEO Chris Garabedian Seeks to Avoid Quick Flip, Build Enduring Drug Company 06/02/11 Seattle
Sangamo Shows Early Promise Against HIV, Hemophilia at Gene Therapy Revival Meeting 05/23/11 San Francisco
Page 2 of 6 « previous page · next page »